Gene · 8318
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| USP37 protects mammalian cells during DNA replication stress by counteracting CUL2LRR1 and TRAIP. | Cell Rep | 2025 | 40411782 | PubTator, text mining | PubMed |
Identification of key biomarker genes in liver hepatocellular carcinoma and kidney renal clear cell carcinoma progression: A shared high-throughput screening and molecular docking method with potentials for targeted therapeutic interventions. | J Genet Eng Biotechnol | 2025 | 40390492 | PubTator, text mining | PubMed |
| USP37 prevents unscheduled replisome unloading through MCM complex deubiquitination. | Nat Commun | 2025 | 40379725 | PubTator, text mining | PubMed |
| Critical role of alpha spectrin in DNA repair: the importance of μ-calpain and Fanconi anemia proteins. | Exp Biol Med (Maywood) | 2025 | 40375875 | PubTator, text mining | PubMed |
| A comprehensive review and in silico analysis of the role of survivin (BIRC5) in hepatocellular carcinoma hallmarks: A step toward precision. | Int J Biol Macromol | 2025 | 40306500 | PubTator, text mining | PubMed |
| Clinical potential and experimental validation of prognostic genes in hepatocellular carcinoma revealed by risk modeling utilizing single cell and transcriptome constructs. | Front Immunol | 2025 | 40255404 | PubTator, text mining | PubMed |
| Identification of Deregulated miRNAs and mRNAs Involved in Tumorigenesis and Detection of Glioblastoma Patients Applying Next-Generation RNA Sequencing. | Pharmaceuticals (Basel) | 2025 | 40143207 | PubTator, text mining | PubMed |
| Effects of CDC45 mutations on DNA replication and genome stability. | Biochim Biophys Acta Mol Cell Res | 2025 | 40139510 | PubTator, text mining | PubMed |
| Functional Analysis and Experimental Validation of the Prognostic and Immune Effects of the Oncogenic Protein CDC45 in Breast Cancer. | Breast Cancer (Dove Med Press) | 2025 | 39811603 | PubTator, text mining | PubMed |
| Cell cycle progression of under-replicated cells. | Nucleic Acids Res | 2025 | 39778868 | PubTator, text mining | PubMed |
| Toward a comprehensive profiling of alternative splicing proteoform structures, interactions and functions. | Curr Opin Struct Biol | 2025 | 39778413 | PubTator, text mining | PubMed |
| Identifying ribonucleotide reductase subunit genes as potential lung adenocarcinomas biomarkers using integrated bioinformatics analysis. | Malawi Med J | 2024 | 40191558 | PubTator, text mining | PubMed |
| Itaconate Ameliorates Experimental Autoimmune Uveitis by Modulating Teff/Treg Cell Imbalance Via the DNAJA1/CDC45 Axis. | Invest Ophthalmol Vis Sci | 2024 | 39661355 | PubTator, text mining | PubMed |
| Analysis of Human Papillomavirus-Associated Cervical Cancer Differentially Expressed Genes and Identification of Prognostic Factors using Integrated Bioinformatics Approaches. | Adv Biomed Res | 2024 | 39512411 | PubTator, text mining | PubMed |
| Integrated network pharmacology and transcriptomic approach reveal the role of equol in reducing colorectal cancer via regulating multiple cell cycle genes in HCT116 cells. | Int J Biol Macromol | 2024 | 39461627 | PubTator, text mining | PubMed |
| Single-molecule insights into repetitive helicases. | J Biol Chem | 2024 | 39424144 | PubTator, text mining | PubMed |
| Single-Molecule Real-Time Visualization of DNA Unwinding by CMG Helicase. | J Vis Exp | 2024 | 39400190 | PubTator, text mining | PubMed |
| Assembly, Activation, and Helicase Actions of MCM2-7: Transition from Inactive MCM2-7 Double Hexamers to Active Replication Forks. | Biology (Basel) | 2024 | 39194567 | PubTator, text mining | PubMed |
| Based on machine learning, CDC20 has been identified as a biomarker for postoperative recurrence and progression in stage I & II lung adenocarcinoma patients. | Front Oncol | 2024 | 39114311 | PubTator, text mining | PubMed |
| Proteome-scale characterisation of motif-based interactome rewiring by disease mutations. | Mol Syst Biol | 2024 | 39009827 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8318/papers?page=4